http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 21 Aug 2026 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html <p align="justify">VANCOUVER, British Columbia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- <strong>Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) </strong>announces that it has entered into a non-binding letter of intent dated August 20, 2026 (the &quot;LOI&quot;) with a private Alberta corporation (the &quot;<strong>Purchaser</strong>&quot;), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the &quot;<strong>Proposed Transaction</strong>&quot;) whereby the Purchaser would acquire all of the issued and outstanding common shares (the &quot;<strong>Shares</strong>&quot;) of the Company. The final structure of the Proposed Transaction has not been determined and, http://www.streetinsider.com/Press+Releases/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html Fri, 21 Aug 2026 07:00:00 -0400 CLB CLC CLCFF O.50579775 http://www.streetinsider.com/Press+Releases/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html <p align="justify">VANCOUVER, British Columbia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- <strong>Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) </strong>announces that it has entered into a non-binding letter of intent dated August 20, 2026 (the &quot;LOI&quot;) with a private Alberta corporation (the &quot;<strong>Purchaser</strong>&quot;), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the &quot;<strong>Proposed Transaction</strong>&quot;) whereby the Purchaser would acquire all of the issued and outstanding common shares (the &quot;<strong>Shares</strong>&quot;) of the Company. The final structure of the Proposed Transaction has not been determined and, http://www.streetinsider.com/Press+Releases/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html Fri, 21 Aug 2026 07:00:00 -0400 CLB CLC CLCFF O.50579775 http://www.streetinsider.com/Press+Releases/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html <p align="justify">VANCOUVER, British Columbia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- <strong>Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) </strong>announces that it has entered into a non-binding letter of intent dated August 20, 2026 (the &quot;LOI&quot;) with a private Alberta corporation (the &quot;<strong>Purchaser</strong>&quot;), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the &quot;<strong>Proposed Transaction</strong>&quot;) whereby the Purchaser would acquire all of the issued and outstanding common shares (the &quot;<strong>Shares</strong>&quot;) of the Company. The final structure of the Proposed Transaction has not been determined and, http://www.streetinsider.com/Press+Releases/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html Fri, 21 Aug 2026 07:00:00 -0400 CLB CLC CLCFF O.50579775 http://www.streetinsider.com/Press+Releases/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html <p align="justify">VANCOUVER, British Columbia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- <strong>Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) </strong>announces that it has entered into a non-binding letter of intent dated August 20, 2026 (the &quot;LOI&quot;) with a private Alberta corporation (the &quot;<strong>Purchaser</strong>&quot;), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the &quot;<strong>Proposed Transaction</strong>&quot;) whereby the Purchaser would acquire all of the issued and outstanding common shares (the &quot;<strong>Shares</strong>&quot;) of the Company. The final structure of the Proposed Transaction has not been determined and, http://www.streetinsider.com/Press+Releases/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html Fri, 21 Aug 2026 07:00:00 -0400 CLB CLC CLCFF O.50579775 http://www.streetinsider.com/Globe+Newswire/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html <p align="justify">VANCOUVER, British Columbia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- <strong>Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) </strong>announces that it has entered into a non-binding letter of intent dated August 20, 2026 (the &quot;LOI&quot;) with a private Alberta corporation (the &quot;<strong>Purchaser</strong>&quot;), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the &quot;<strong>Proposed Transaction</strong>&quot;) whereby the Purchaser would acquire all of the issued and outstanding common shares (the &quot;<strong>Shares</strong>&quot;) of the Company. The final structure of the Proposed Transaction has not been determined and, http://www.streetinsider.com/Globe+Newswire/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html Fri, 21 Aug 2026 07:00:00 -0400 CLB CLC CLCFF O.50579775 http://www.streetinsider.com/Globe+Newswire/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html <p align="justify">VANCOUVER, British Columbia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- <strong>Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) </strong>announces that it has entered into a non-binding letter of intent dated August 20, 2026 (the &quot;LOI&quot;) with a private Alberta corporation (the &quot;<strong>Purchaser</strong>&quot;), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the &quot;<strong>Proposed Transaction</strong>&quot;) whereby the Purchaser would acquire all of the issued and outstanding common shares (the &quot;<strong>Shares</strong>&quot;) of the Company. The final structure of the Proposed Transaction has not been determined and, http://www.streetinsider.com/Globe+Newswire/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html Fri, 21 Aug 2026 07:00:00 -0400 CLB CLC CLCFF O.50579775 http://www.streetinsider.com/Globe+Newswire/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html <p align="justify">VANCOUVER, British Columbia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- <strong>Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) </strong>announces that it has entered into a non-binding letter of intent dated August 20, 2026 (the &quot;LOI&quot;) with a private Alberta corporation (the &quot;<strong>Purchaser</strong>&quot;), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the &quot;<strong>Proposed Transaction</strong>&quot;) whereby the Purchaser would acquire all of the issued and outstanding common shares (the &quot;<strong>Shares</strong>&quot;) of the Company. The final structure of the Proposed Transaction has not been determined and, http://www.streetinsider.com/Globe+Newswire/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html Fri, 21 Aug 2026 07:00:00 -0400 CLB CLC CLCFF O.50579775 http://www.streetinsider.com/Globe+Newswire/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html <p align="justify">VANCOUVER, British Columbia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- <strong>Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) </strong>announces that it has entered into a non-binding letter of intent dated August 20, 2026 (the &quot;LOI&quot;) with a private Alberta corporation (the &quot;<strong>Purchaser</strong>&quot;), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the &quot;<strong>Proposed Transaction</strong>&quot;) whereby the Purchaser would acquire all of the issued and outstanding common shares (the &quot;<strong>Shares</strong>&quot;) of the Company. The final structure of the Proposed Transaction has not been determined and, http://www.streetinsider.com/Globe+Newswire/Christina+Lake+Cannabis+Announces+Non-Binding+Letter+of+Intent/26958391.html Fri, 21 Aug 2026 07:00:00 -0400 CLB CLC CLCFF O.50579775 http://www.streetinsider.com/Upgrades/Johnson+Rice+Upgrades+Core+Laboratories+%28CLB%29+to+Buy/26918231.html <p>Johnson Rice analyst Don Crist upgraded Core Laboratories (NYSE: CLB) from Hold to Buy with a price target of $21.00.</p><p>For an analyst ratings summary and ratings history on Core Laboratories <a href="http://www.streetinsider.com/rating_history.php?q=CLB">click here</a>. For more ratings news on Core Laboratories <a href="http://www.streetinsider.com/stock_lookup_news.php?q=CLB&amp;type=analyst">click here</a>.</p><p>Shares of Core Laboratories closed at $12.45 yesterday.</p> http://www.streetinsider.com/Upgrades/Johnson+Rice+Upgrades+Core+Laboratories+%28CLB%29+to+Buy/26918231.html Thu, 13 Aug 2026 10:34:08 -0400 CLB http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Jul+31++Filed+by%3A+Bruno+Lawrence/26863741.html si-local-file:///var/storage/secattach/20260804/26863741.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Jul+31++Filed+by%3A+Bruno+Lawrence/26863741.html Tue, 04 Aug 2026 10:40:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Jul+31++Filed+by%3A+Bruno+Lawrence/26863741.html si-local-file:///var/storage/secattach/20260804/26863741.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Jul+31++Filed+by%3A+Bruno+Lawrence/26863741.html Tue, 04 Aug 2026 10:40:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Aug+01++Filed+by%3A+Teo+Sow+Hang/26863722.html si-local-file:///var/storage/secattach/20260804/26863722.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Aug+01++Filed+by%3A+Teo+Sow+Hang/26863722.html Tue, 04 Aug 2026 10:36:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Aug+01++Filed+by%3A+Teo+Sow+Hang/26863722.html si-local-file:///var/storage/secattach/20260804/26863722.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Aug+01++Filed+by%3A+Teo+Sow+Hang/26863722.html Tue, 04 Aug 2026 10:36:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Aug+01++Filed+by%3A+Tattoli+Mark+Damian/26863646.html si-local-file:///var/storage/secattach/20260804/26863646.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Aug+01++Filed+by%3A+Tattoli+Mark+Damian/26863646.html Tue, 04 Aug 2026 10:27:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Aug+01++Filed+by%3A+Tattoli+Mark+Damian/26863646.html si-local-file:///var/storage/secattach/20260804/26863646.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Aug+01++Filed+by%3A+Tattoli+Mark+Damian/26863646.html Tue, 04 Aug 2026 10:27:00 -0400 CLB O.00555479 http://www.streetinsider.com/Earnings/Core+Laboratories+%28CLB%29+Misses+Q2+EPS+by+17c/26837544.html <p>Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.13, $0.17 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $124.6 million.</p><p>For earnings history and earnings-related data on Core Laboratories (CLB) <a href="http://www.streetinsider.com/ec_earnings.php?q=CLB">click here</a>.</p> http://www.streetinsider.com/Earnings/Core+Laboratories+%28CLB%29+Misses+Q2+EPS+by+17c/26837544.html Thu, 30 Jul 2026 05:53:25 -0400 CLB http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307 http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307 http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307 http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307 http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307 http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307 http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307 http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307 http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF $</b><b>124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF $</b><b>9.2 MILLION; EX-ITEMS, <money>$9.4 MILLION</money>, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR</b></li><li><b>GAAP EARNINGS PER </b><b>SHARE</b><b> OF</b><b> <money>$0.13</money>; EPS EX-ITEMS OF <money>$0.11</money>, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF $</b><b>3.1 MILLION</b></li><li><b>COMPANY REPURCHASED 214,712</b><b> SHARES OF COMMON STOCK, FOR <money>$2.7 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>July 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported second quarter 2026 revenue of <money>$124,600,000</money>. Core's operating income was <money>$9,200,000</money>, with earnings http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+SECOND+QUARTER+2026+RESULTS/26836473.html Wed, 29 Jul 2026 17:15:00 -0400 A.50216777 CLB CLB O.00555479 O.54979307